Covered recipient · General Payments record
ERIC D DONNENFELD
Allopathic & Osteopathic Physicians Ophthalmology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2024 · Entire year
$116,410.18
156 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2024 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $78,376.98 | 32 |
| Compensation for serving as faculty or as a speaker for a medical education program | $18,912.50 | 8 |
| Gift | $10,000.00 | 1 |
| Food and Beverage | $5,496.52 | 108 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,150.00 | 2 |
| Honoraria | $775.59 | 2 |
| Travel and Lodging | $698.59 | 3 |
By paying entity
PY2024 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bausch & Lomb Americas Inc. | $33,116.88 | 33 |
| Johnson & Johnson Surgical Vision, Inc. | $27,107.84 | 24 |
| Nordic Pharma, Inc. | $13,057.31 | 1 |
| TearLab Corp | $10,000.00 | 1 |
| Tarsus Pharmaceuticals, Inc. | $7,815.04 | 25 |
| Alcon Research LLC | $6,625.76 | 6 |
| Amgen Inc. | $4,000.00 | 2 |
| Hoya Surgical Optics, Inc | $4,000.00 | 1 |
| ABBVIE INC. | $2,385.39 | 12 |
| Alcon Vision LLC | $1,618.31 | 10 |
| Sight Sciences, Inc. | $1,500.00 | 2 |
| Harrow Eye, LLC | $1,448.46 | 4 |
| Carl Zeiss Meditec, Inc. | $1,191.45 | 2 |
| Glaukos Corporation | $955.73 | 6 |
| Topcon Healthcare, Inc. | $750.00 | 1 |
| BIOTISSUE HOLDINGS INC. | $209.84 | 3 |
| RxSight Inc | $183.48 | 3 |
| ANI Pharmaceuticals, Inc. | $145.09 | 6 |
| Oyster Point Pharma, Inc. | $90.10 | 5 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $86.26 | 4 |
| Ocular Therapeutix, Inc. | $56.02 | 3 |
| Rayner Intraocular Lenses Limited | $33.71 | 1 |
| Dompe US, Inc. | $33.51 | 1 |
Page 4 of 4; records 151–156 of 156 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
ERIC D DONNENFELD
NPI 1891790770 · CMS profile ID 40572
Allopathic & Osteopathic Physicians / Ophthalmology
GARDEN CITY, NY
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 4 of 4; records 151–156 of 156 matching records. This page contains 6 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1891790770?year=2024&recipient=provider&page=4#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- ERIC D DONNENFELD, NPI 1891790770, CMS profile ID 40572. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–156 of 156 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1891790770?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- APA 7
- IndustryPayments. (2026). ERIC D DONNENFELD, NPI 1891790770, CMS profile ID 40572. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–156 of 156 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1891790770?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- Bluebook
- ERIC D DONNENFELD, NPI 1891790770, CMS profile ID 40572, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–156 of 156 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1891790770?year=2024&recipient=provider&page=4#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2024
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30
156 matching records · $116,410.18 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 151–156 of 156.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | $24.78 | 01/12/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1077600232 | CMS |
| Johnson & Johnson Surgical Vision, Inc. | $18.88 | 01/12/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1077600236 | CMS |
| Johnson & Johnson Surgical Vision, Inc. | $22.23 | 01/12/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1077600242 | CMS |
| Johnson & Johnson Surgical Vision, Inc. | $311.72 | 01/11/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1077600230 | CMS |
| BIOTISSUE HOLDINGS INC. | $95.33 | 01/08/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1148752284 | CMS |
| Oyster Point Pharma, Inc. | $16.48 | 01/08/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147420872 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $8,625.00 | 1 |
| PY2025 | Principal investigator | $140,078.00 | 8 |
| PY2024 | Recipient | $14,775.00 | 2 |
| PY2024 | Principal investigator | $204,660.00 | 17 |
| PY2023 | Recipient | $51,700.00 | 2 |
| PY2023 | Principal investigator | $304,212.00 | 15 |
| PY2022 | Recipient | $91,561.71 | 3 |
| PY2021 | Principal investigator | $128,765.54 | 5 |
| PY2020 | Principal investigator | $98,530.00 | 5 |
| PY2019 | Principal investigator | $320,898.63 | 8 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
9 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $1,000.00 | 12/22/2025 | Non-covered Recipient Entity ERIC D DONNENFELD MD PC | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction | No dispute reported | 06/30/2026 | 1246979396 |
| Recipient | Rayner Intraocular Lenses Limited | $8,625.00 | 06/16/2025 | Covered Recipient Physician | Not supplied | No dispute reported | 06/30/2026 | 1211224363 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $31,738.00 | 06/15/2025 | Non-covered Recipient Entity DLS Consulting | Evaluating the Effect of Xiidra w Dry Eye Study # LFGST-2018-01 | No dispute reported | 06/30/2026 | 1246979283 |
| Principal investigator 1 | Johnson & Johnson Surgical Vision, Inc. | $13,000.00 | 05/01/2025 | Non-covered Recipient Entity DHS CONSULTING | Clinical Investigation of the TECNIS Next-Generation Intraocular Lens | No dispute reported | 06/30/2026 | 1174793963 |
| Principal investigator 1 | Johnson & Johnson Surgical Vision, Inc. | $9,750.00 | 03/31/2025 | Non-covered Recipient Entity DHS CONSULTING | Clinical Investigation of the TECNIS Next-Generation Intraocular Lens | No dispute reported | 06/30/2026 | 1174793943 |
| Principal investigator 1 | Rayner Intraocular Lenses Limited | $525.00 | 03/17/2025 | Non-covered Recipient Entity ADVARRA INC | Not supplied | No dispute reported | 06/30/2026 | 1211224361 |
| Principal investigator 1 | Johnson & Johnson Surgical Vision, Inc. | $22,750.00 | 03/03/2025 | Non-covered Recipient Entity DHS CONSULTING | Clinical Investigation of the TECNIS Next-Generation Intraocular Lens | No dispute reported | 06/30/2026 | 1174793931 |
| Principal investigator 1 | Johnson & Johnson Surgical Vision, Inc. | $58,750.00 | 01/30/2025 | Non-covered Recipient Entity DHS CONSULTING | Clinical Investigation of the TECNIS Next-Generation Intraocular Lens | No dispute reported | 06/30/2026 | 1174793952 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $2,565.00 | 01/02/2025 | Non-covered Recipient Entity ERIC D DONNENFELD MD PC | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction | No dispute reported | 06/30/2026 | 1246979392 |
Ownership and Investment Interests
One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together
| Program year | Measure | Amount | Records |
|---|---|---|---|
| PY2025 | Amount invested | $500.00 | 1 |
| PY2025 | Value of interest | $7,001.26 | 1 |
| PY2024 | Amount invested | $51,749.47 | 3 |
| PY2024 | Value of interest | $95,456.47 | 3 |
| PY2023 | Amount invested | $50,000.00 | 2 |
| PY2023 | Value of interest | $90,789.79 | 2 |
| PY2022 | Amount invested | $50,000.00 | 2 |
| PY2022 | Value of interest | $90,789.79 | 2 |
| PY2021 | Amount invested | $399,975.00 | 2 |
| PY2021 | Value of interest | $40,827.59 | 2 |
| PY2020 | Amount invested | $440,764.79 | 2 |
| PY2020 | Value of interest | $40,827.59 | 2 |
| PY2019 | Amount invested | $399,975.00 | 2 |
| PY2019 | Value of interest | $80,031.40 | 2 |
Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.
Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.
Ownership and Investment Interests records
Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them
14 records · PY2019–2025
| Program year | Company | Amount invested | Value of interest | Terms of interest | Interest held by | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| PY2025 | LENSAR, INC. | $500.00 | $7,001.26 | Ownership Interest | Physician Covered Recipient | No dispute reported | 06/30/2026 | 1250209903 |
| PY2024 | EyePoint Pharmaceuticals US, Inc. | $0.00 | $40,789.79 | Vested Stock Options; use Black-Scholes Valuation to determine value of interest and dollar amount invested | Physician Covered Recipient | No dispute reported | 06/30/2026 | 1132968111 |
| PY2024 | LENSAR, INC. | $1,749.47 | $4,666.68 | Ownership Interest | Immediate family member | No dispute reported | 06/30/2026 | 1153336214 |
| PY2024 | TearOptix, Inc. | $50,000.00 | $50,000.00 | Preferred Stock | Physician Covered Recipient | No dispute reported | 06/30/2026 | 1145403157 |
| PY2023 | EyePoint Pharmaceuticals US, Inc. | $0.00 | $40,789.79 | Vested Stock Options; use Black-Scholes Valuation to determine value of interest and dollar amount invested | Physician Covered Recipient | No dispute reported | 06/30/2026 | 1025212561 |
| PY2023 | TearOptix, Inc. | $50,000.00 | $50,000.00 | Preferred Stock | Physician Covered Recipient | No dispute reported | 06/30/2026 | 1039958925 |
| PY2022 | EyePoint Pharmaceuticals US, Inc. | $0.00 | $40,789.79 | Vested Stock Options; use Black-Scholes Valuation to determine value of interest and dollar amount invested | Physician Covered Recipient | No dispute reported | 06/30/2026 | 924923897 |
| PY2022 | TearOptix, Inc. | $50,000.00 | $50,000.00 | Preferred Stock | Physician Covered Recipient | No dispute reported | 06/30/2026 | 957789753 |
| PY2021 | EyePoint Pharmaceuticals US, Inc. | $0.00 | $40,789.79 | Vested Stock Options; use Black-Scholes Valuation to determine value of interest and dollar amount invested | Physician Covered Recipient | No dispute reported | 06/30/2026 | 813407779 |
| PY2021 | Rapid Pathogen Screening, Inc. | $399,975.00 | $37.80 | common stock | Physician Covered Recipient | No dispute reported | 06/30/2026 | 760993596 |
| PY2020 | EyePoint Pharmaceuticals US, Inc. | $40,789.79 | $40,789.79 | Vested Stock Options; use Black-Scholes Valuation to determine value of interest and dollar amount invested | Physician Covered Recipient | No dispute reported | 06/30/2026 | 736582287 |
| PY2020 | Rapid Pathogen Screening, Inc. | $399,975.00 | $37.80 | common stock | Physician Covered Recipient | No dispute reported | 06/30/2026 | 737343711 |
| PY2019 | EyePoint Pharmaceuticals US, Inc. | $0.00 | $79,999.00 | Stock Option Grant on 8 April 2019 use Black-Scholes Valuation to determine value of interest | Physician Covered Recipient | No dispute reported | 06/30/2026 | 698075405 |
| PY2019 | Rapid Pathogen Screening, Inc. | $399,975.00 | $32.40 | common stock | Physician Covered Recipient | No dispute reported | 06/30/2026 | 655123217 |